Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.148 (
Thy1
)
1,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using the monoclonal antibodies OX7 HL, W3/13 HLK, OX1 HLK, OX22, and the technique of fluorescence activated cell sorting, it was possible to characterize the phenotype of the rat marrow CFU-S as OX7 upper 20% positive, W3/13 lower 50% positive, OX1 positive, and OX22 negative. OX7 recognizes an antigenic determinant expressed on the
Thy1
glycoprotein, W3/13 recognizes a determinant expressed on some sialoglycoproteins, OX1 recognizes all four apparent molecular weight forms of
leukocyte common antigen
, while OX22 recognizes only the high molecular weight forms of
leukocyte common antigen
. It was determined that the concentration of OX7 upper 20% positive, W3/13 lower 50% positive, OX1 positive, and OX22 negative cells in the marrow was 3085 +/- 1446/10(6) cells. For comparison, the calculated concentration of marrow stem cells using a 2-h seeding efficiency was found to be 501 CFU-S/10(6) cells and, using a 24-h seeding efficiency, it was found to be 1415 CFU-S/10(6) cells. Although requiring further refinements, these results suggest that an assessment of CFU-S marrow concentration might be achieved using multiparameter flow cytometry. Also, a technique for the conjugation of the Fab' fragment of the monoclonal antibody OX7 to phycoerythrin is described.
...
PMID:Rat colony-forming unit spleen is OX7 positive, W3/13 positive, OX1 positive, and OX22 negative. 286 77